Stay updated with breaking news from Adaptive Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The future direction of Federal Reserve interest rate policy as well as opportunities tied to artificial intelligence remain hot topics among investors.
Researchers found improved outcomes for PT-Cy using a composite study endpoint of GVHD-free and relapse-free survival, but the regimens had similar overall survival and relapse-free survival outcomes.
Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical ...
Adaptive Biotech product 'clonoSEQ' is the first MRD test cleared by FDA for multiple myeloma, CLL, and B-ALL. See why investors should consider adding ADPT stock to their portfolio.
Wood's Ark Investment Management continues its buying and selling of stocks -- mostly buying.